Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

18°
- Ridgway, PA (15853)
  Today
  
  Light snow this evening will give way to cloudy skies late. Low around -5F. Winds NW at 15 to 25 mph. Chance of snow 60%. Higher wind gusts possible..
  
  Tonight
  
  Light snow this evening will give way to cloudy skies late. Low around -5F. Winds NW at 15 to 25 mph. Chance of snow 60%. Higher wind gusts possible.
  
  Updated: February 6, 2026 @ 11:33 pm
- Full Forecast

Site search

Home
News
Sports
Obituaries
Photos
e-Edition
Classifieds
- Place an ad
Best of 2025
Archives
Share News

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

41.01 +0.14 (+0.34%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Moderna to Present at Upcoming Conferences in September 2025

August 21, 2025

Via ACCESS Newswire

Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates

August 01, 2025

Via ACCESS Newswire

UK Court of Appeal Confirms Moderna’s EP'949 Patent is Valid and Infringed by Pfizer/BioNTech

August 01, 2025

Via ACCESS Newswire

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

July 30, 2025

Via ACCESS Newswire

Moderna Announces Data to be Presented at ESMO Congress 2025

July 28, 2025

Via ACCESS Newswire

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE

May 31, 2025

Via ACCESS Newswire

Moderna Announces Update on Investigational Pandemic Influenza Program

May 28, 2025

Via ACCESS Newswire

Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine

February 28, 2025

Via ACCESS Newswire

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1

July 25, 2025

Via ACCESS Newswire

Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine

June 30, 2025

Via ACCESS Newswire

Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease

June 12, 2025

Via ACCESS Newswire

Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025

June 11, 2025

Via ACCESS Newswire

Moderna to Present at Upcoming Conferences in June 2025

May 27, 2025

Via ACCESS Newswire

Moderna to Present at Upcoming Conferences in March 2025

February 25, 2025

Via ACCESS Newswire

Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union

January 24, 2025

Via ACCESS Newswire

Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference

January 13, 2025

Via ACCESSWIRE

Moderna to Present at Upcoming Conferences in December 2024

November 25, 2024

Via ACCESSWIRE

Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine

May 23, 2025

Via ACCESS Newswire

Moderna Provides Update on BLA Submission for Combination Vaccine Against Influenza and COVID-19

May 21, 2025

Via ACCESS Newswire

Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025

May 08, 2025

Via ACCESS Newswire

Moderna Reports First Quarter 2025 Financial Results and Provides Business Updates

May 01, 2025

Via ACCESS Newswire

Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

April 10, 2025

Via ACCESS Newswire

Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older

November 08, 2024

Via ACCESSWIRE

Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates

November 07, 2024

Via ACCESSWIRE

Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025

April 07, 2025

Via ACCESS Newswire

Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults

March 31, 2025

Via ACCESS Newswire

Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates

February 14, 2025

Via ACCESS Newswire

Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025

January 29, 2025

Via ACCESS Newswire

Moderna Announces Updates on Pandemic Influenza Program

January 17, 2025

Via ACCESS Newswire

Moderna Tops BioSpace's Best Places to Work Ranking for Fourth Consecutive Year

November 12, 2024

Via ACCESSWIRE

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Announcements
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

The Ridgway Record

RidgwayRecord.com
325 Main Street, Suite A
RIdgway, PA 15853
Phone: 814-773-3161
Email: editorial@ridgwayrecord.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Ridgway, PA (15853)

Today

Tonight

Moderna, Inc. - Common Stock (NQ:MRNA)

Press Releases about Moderna, Inc. - Common Stock

Sections

Services

The Ridgway Record